Ashwagandha Improves Memory in Adults with Mild Cognitive Impairment
A new clinical study of Somin-On™, an ashwagandha (Withania somnifera) withanolide extract standardized to Sominone, highlights its potential for improving memory and cognitive function in adults with mild cognitive impairment (MCI). Somin-on is the newest addition to Arjuna Natural, Pvt. Ltd.’s prized portfolio of branded botanical formulations. Unique to this ashwagandha formulation is that it is standardized to a 2% content Sominone (established via HPLC) and is designed to focus primarily on enhancing specific cognitive functions, such as attention and memory retention.